Beta-Caryophyllene Supplements: Evidence, Formulations and Responsible Use
Updated: 14 hours ago

Beta-caryophyllene supplements contain BCP, a plant-derived terpene studied for its interaction with CB2 receptors. Oral BCP supplements differ in their active BCP amount, ingredient source, serving size and delivery format, including capsules and liposomal drops. This guide compares these formulation details and the available research so readers can evaluate what each supplement provides. BCPlus topical products are covered separately because they are intended for external application.
Research areas include CB2 signaling, immune biology, metabolism, topical delivery, and oral formulations.
What is beta-caryophyllene?
BCP is a terpene present in cloves, black pepper, hops, and other plants. It can interact with cannabinoid receptor 2 (CB2), a receptor involved in immune and inflammatory signaling. BCP is not intoxicating, and its CB2 activity is different from the CB1 activity associated with THC.
Start with BCP Fundamentals for an introduction, then explore what BCP research shows for study-level context.
What the research shows
Preclinical evidence.Cell and animal studies help researchers examine mechanisms such as inflammatory signaling, oxidative stress, metabolic pathways, and tissue responses. These models can identify promising questions, but they cannot predict a person’s outcome.
Human evidence.Human research is smaller and varies by BCP source, amount, delivery format, study duration, and population. Results depend on the formulation studied.
For published human study designs and findings, read What Have Human Studies Discovered About Beta-Caryophyllene? to distinguish results involving BCP itself from results involving multi-ingredient formulations.
Clinical interpretation.A responsible review asks what was studied, in whom, at what amount, for how long, and against which comparison. Mechanistic findings and associations should not be presented as guaranteed benefits.
How supplement formulations differ
Source.“Plant-derived” is broad. Blair Medical Group identifies BCP sources by formulation. BCPlus Topical Gel uses hops-derived BCP; some other BCPlus products use clove-derived BCP.
Standardization and active amount. A powder or blend can contain both BCP and other material. Its total weight is therefore different from the amount of active beta-caryophyllene it provides. Compare the declared active amount per serving, together with the serving size and the full ingredient list.
Delivery format. Oral capsules, liposomal drops, topical tinctures and gels have different intended uses and formulation designs. Read how liposomal BCP delivery works for an explanation of the liquid carrier format.
Companion ingredients.OEA, piperine, terpenes, essential oils, and carrier systems each add a separate formulation context. Evidence about one ingredient should not be attributed automatically to the complete product.
Documentation.Look for clear labels, ingredient amounts, directions, and available batch or testing documentation.Review available Certificates of Analysis.
Current BCPlus formulation formats
Product | Use | Delivery format | Package size | Defining ingredients or features | Product details |
BCPlus Oral Liposomal Drops 60ml | Oral | Liposomal liquid | 60 mL | Clove-derived BCP in a water-dispersible liquid with sunflower lecithin | |
BCPlus Metabolic Blend Capsules | Oral | Enteric-coated vegetarian capsules | 60 capsules | Clove-derived BCP with OEA and piperine | |
BCPlus Immunity Blend Capsules | Oral | Enteric-coated vegetarian capsules | 60 capsules | BCP with turmeric, ginger, curcumin and piperine | |
BCPlus Topical Gel 120ml | Topical | Water-based gel | 120 mL | Hops-derived BCP in a DMAE gel with a botanical blend | |
BCPlus Topical Tincture 30ml | Topical | Liquid dropper | 30 mL | Clove-derived BCP with complementary terpenes and botanical extracts |
Explore the five BCPlus formulations listed above and review their current product details and availability in the BCPlus product catalog.
Questions to ask before choosing a BCP supplement
Where does the BCP come from? How much active BCP is provided per serving? Is the amount stated clearly? What delivery format is used? Which additional ingredients are present? Does the evidence relate to the complete formulation or only to one ingredient? Are directions and documentation available?
Responsible use
Follow the product label and do not assume that more is better. Work with a qualified healthcare practitioner when you need personal guidance, especially if you manage a diagnosed condition, take medication, are preparing for a procedure, or are pregnant or breastfeeding.
Track one small, consistent adjustment at a time when practical. That makes it easier to notice tolerance, routine, and questions worth discussing with a practitioner.
Frequently asked questions
Is BCP the same as CBD?
BCP is a terpene and a selective CB2 receptor agonist. CBD is a different compound with a different pharmacologic profile.
Does BCP cause intoxication?
BCP is non-intoxicating. Its CB2 activity is distinct from the CB1 activity associated with THC.
Do all BCP supplements provide the same amount?
Sources, concentrations, serving sizes, delivery systems and companion ingredients vary. Compare the active BCP amount per serving alongside the full formulation and intended route of use.
What areas of BCP research are currently being explored?
Research areas include CB2 signaling, immune biology, metabolism, topical delivery and oral formulations. The study design identifies whether a finding comes from laboratory work, animal research or a study in people.
Continue learning
Visit the BMG Resource Hub, reviewDr. Blair’s clinical background, or readBeta-Caryophyllene and Metabolic Health: What the Evidence Shows.
Reviewed:September 1, 2026
Editorial update: October 15, 2026.
Research references
Gertsch et al. (2008): BCP and CB2 receptor activity. Receptor, cell and mouse experiments identified beta-caryophyllene as a selective CB2 agonist and examined its activity in inflammatory signaling.
Mödinger et al. (2022): human BCP absorption study. A randomized crossover study in 24 healthy adults compared a VESIsorb self-emulsifying BCP formulation with BCP oil. Blood-concentration measurements showed higher exposure and faster absorption with the tested self-emulsifying preparation.
Alizadeh et al. (2022): BCP and food-addiction scores. An eight-week randomized trial in women with obesity and food-addiction symptoms tested 100 mg BCP daily. Food-addiction scores improved relative to placebo; appetite, body-composition and anthropometric outcomes showed no significant between-group differences.





Comments